Department of Medicine 4 – Nephrology and Hypertension

PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease (2024) Kannenkeril D, Bosch A, Kolwelter J, Striepe K, Berner L, Pietschner R, Ott C, et al. Journal article Predicting blood pressure response to renal denervation based on a new approach (2024) Bytyqi V, Kannenkeril D, Striepe K, Bosch A, Karg MV, Schmid A, Schiffer M, et al. Journal article Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study (2024) Gruber I, Kollerits B, Forer L, Di Maio S, Schachtl-Riess JF, Kheirkhah A, Schönherr S, et al. Journal article Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis (2024) Vukadinovic D, Lauder L, Kandzari DE, Bhatt DL, Kirtane AJ, Edelman ER, Schmieder R, et al. Journal article Das ROSE-Konzept – modernes Flüssigkeitsmanagement in der Intensivmedizin (2024) Willam C, Herbst L Journal article Current status of nephroprotection in diabetology Aktueller Stand der Nephroprotektion in der Diabetologie (2024) Schmieder R, Striepe K Journal article P2Y2R and Cyst Growth in Polycystic Kidney Disease. (2024) Kraus A, Skoczynski K, Brötsch M, Burzlaff N, Leipziger J, Schiffer M, Büttner-Herold M, Buchholz B Journal article Renal adaptation in pre-obesity patients with hypertension (2024) Bosch A, Rauh M, Striepe K, Schiffer M, Schmieder R, Kannenkeril D Journal article Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real-world settings: Insights from REVEAL-CKD (2024) Tangri N, Alvarez CS, Arnold M, Barone S, Cebrián A, Chen H, De Nicola L, et al. Journal article Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial (2024) Mann JF, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, et al. Journal article